Drug developers have been acquiring complimentary programs to reduce execution risk and maintain investor interest.

Wellness has gone to a trillion-dollar lifestyle, and EZZ Life Science is diving straight into America’s booming self-care ...

Quarterly season is almost done, and David Franklyn joins to give his best and worst September gold performers, plus a ...